The Warfarin Sodium Tablets, cataloged under National Stock Number 6505-00-982-4230, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 6 commercial cross-references from 5 manufacturers, enabling identification through both NSN and commercial part number lookups. 5 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-982-4230 |
| Primary Part Number | NDC76282-0328-01 |
| Item Name | Warfarin Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals |
| Status | ACTIVE |
| Therapeutic Equivalent | COUMADIN BY DUPONT |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Content Quantity | 100.000 TABLETS |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 2.000 MILLIGRAMS WARFARIN SODIUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC76282-0328-01 PRIMARY | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals (USA) |
| NDC51672-4028-01 PRIMARY | Taro Pharmaceuticals U.s.a., Inc. (USA) |
| COUMADIN | Bristol-Myers Squibb Pharma Company (USA) |
| NDC51407-0785-01 | Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc (USA) |
| COUMADIN TABLETS | Bristol-Myers Squibb Pharma Company (USA) |
| NDC00093-1713-01 | Teva Pharmaceuticals Usa, Inc. (USA) |
NSN 6505-00-982-4230 is a Warfarin Sodium Tablets, manufactured by Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-00-982-4230 has 6 cross-referenced part numbers: NDC76282-0328-01 (Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals), NDC51672-4028-01 (Taro Pharmaceuticals U.s.a., Inc.), COUMADIN (Bristol-Myers Squibb Pharma Company), NDC51407-0785-01 (Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc), COUMADIN TABLETS (Bristol-Myers Squibb Pharma Company) and 1 more.
There are 5 known substitutes for 6505-00-982-4230: 6505-00-973-8502, 6505-01-049-1815, 6505-01-052-2857 and 2 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC76282-0328-01: Therapeutic Equivalent: COUMADIN BY DUPONT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 100.000 TABLETS; Primary Container Type: BOTTLE. 6 total characteristics are documented in the Federal Logistics Information System.